Expertise in
10
conditions

Jacques Mansourati

CHU De Brest
Brest, FR 
Expertise in
10
conditions
CHU De Brest
Brest, FR 

Overview

Jacques Mansourati practices practicing medicine in Brest, France.

Mr. Mansourati is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Brugada Syndrome, Fainting, Ventricular Fibrillation, Cardiac Ablation, and Pacemaker Implantation.

He is actively involved in clinical research, co-authoring 132 peer reviewed articles and participating in 12 clinical trials.

Gender

Male

Locations

CHU de Brest
Brest, 29200, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Diagnostic Accuracy of the ATE Score for the Exclusion of Intra-atrial Thrombi Before Catheter Ablation of Atrial Fibrillation: a Confirmatory Study
Diagnostic Accuracy of the ATE Score for the Exclusion of Intra-atrial Thrombi Before Catheter Ablation of Atrial Fibrillation: a Confirmatory Study
Enrollment Status: Completed
Publish Date: March 19, 2026
Intervention Type: Diagnostic test
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Enrollment Status: Active_not_recruiting
Publish Date: October 20, 2025
Intervention Type: Other
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drugs: Alcoholic Povidone Iodine, Alcoholic Chlorhexidine
Study Phase: Phase 4
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Device
Impact Pronostique d'un événement Rythmique Ventriculaire Durant le Port de la LifeVest en Post-infarctus
Impact Pronostique d'un événement Rythmique Ventriculaire Durant le Port de la LifeVest en Post-infarctus
Enrollment Status: Completed
Publish Date: March 10, 2023
Intervention Type: Other
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Enrollment Status: Completed
Publish Date: July 19, 2022
Study of the Impact of Welding Fumes on the Arterial System : RISCAS Study
Study of the Impact of Welding Fumes on the Arterial System : RISCAS Study
Enrollment Status: Terminated
Publish Date: May 05, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
CIQTP Prolongation : Role and Mechanism in Sudden Cardiac Death
CIQTP Prolongation : Role and Mechanism in Sudden Cardiac Death
Enrollment Status: Completed
Publish Date: March 17, 2021
Intervention Type: Other
Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector
Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector
Enrollment Status: Unknown
Publish Date: September 17, 2019
Intervention Type: Device
Study Phase: Not Applicable
BIO|MASTER.Ilivia Family / Plexa
BIO|MASTER.Ilivia Family / Plexa
Enrollment Status: Completed
Publish Date: May 22, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

132 Total Publications

Apparent premature battery depletion in a third-generation subcutaneous implantable cardioverter-defibrillator caused by charge count-based longevity estimation failure: A previously unreported mechanism.
Apparent premature battery depletion in a third-generation subcutaneous implantable cardioverter-defibrillator caused by charge count-based longevity estimation failure: A previously unreported mechanism.
Journal: HeartRhythm case reports
Published: June 18, 2026

Frequently Asked Questions about Jacques Mansourati

Is Jacques Mansourati a top-rated expert for Brugada Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Jacques Mansourati is classified as an Elite expert for Brugada Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jacques Mansourati participate in research or clinical trials?

Yes. Jacques Mansourati has published 132 articles and abstracts on conditions like Brugada Syndrome. You can view a list of Jacques Mansourati's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mansourati's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile